Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.

Song KR, Chapagain RH, Tamrakar D, Shrestha R, Kanodia P, Chaudhary S, Wartel TA, Yang JS, Kim DR, Lee J, Park EL, Cho H, Lee J, Thaisrivichai P, Vemula S, Kim BM, Gupta B, Saluja T, Pansuriya RK, Ganapathy R, Baik YO, Lee YJ, Jeon S, Park Y, Her HL, Park Y, Lynch JA

Open source

DOI: 10.1016/s2214-109x(24)00059-7
Published: 2024 May
Container: The Lancet. Global health
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2214-109x-24-00059-7,
  title = {Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.},
  author = {Song KR and Chapagain RH and Tamrakar D and Shrestha R and Kanodia P and Chaudhary S and Wartel TA and Yang JS and Kim DR and Lee J and Park EL and Cho H and Lee J and Thaisrivichai P and Vemula S and Kim BM and Gupta B and Saluja T and Pansuriya RK and Ganapathy R and Baik YO and Lee YJ and Jeon S and Park Y and Her HL and Park Y and Lynch JA},
  year = {2024},
  journal = {The Lancet. Global health},
  doi = {10.1016/s2214-109x(24)00059-7},
  url = {https://doi.org/10.1016/s2214-109x(24)00059-7}
}

RIS

TY  - JOUR
TI  - Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
AU  - Song KR
AU  - Chapagain RH
AU  - Tamrakar D
AU  - Shrestha R
AU  - Kanodia P
AU  - Chaudhary S
AU  - Wartel TA
AU  - Yang JS
AU  - Kim DR
AU  - Lee J
AU  - Park EL
AU  - Cho H
AU  - Lee J
AU  - Thaisrivichai P
AU  - Vemula S
AU  - Kim BM
AU  - Gupta B
AU  - Saluja T
AU  - Pansuriya RK
AU  - Ganapathy R
AU  - Baik YO
AU  - Lee YJ
AU  - Jeon S
AU  - Park Y
AU  - Her HL
AU  - Park Y
AU  - Lynch JA
PY  - 2024
JO  - The Lancet. Global health
DO  - 10.1016/s2214-109x(24)00059-7
UR  - https://doi.org/10.1016/s2214-109x(24)00059-7
ER  -

APA

KR, S., RH, C., D, T., R, S., P, K., S, C., TA, W., JS, Y., DR, K., J, L., EL, P., H, C., J, L., P, T., S, V., BM, K., B, G., T, S., RK, P., R, G., YO, B., YJ, L., S, J., Y, P., HL, H., Y, P., & JA, L. (2024). Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.. The Lancet. Global health. https://doi.org/10.1016/s2214-109x(24)00059-7

Source records

pubmed · retrieved 2026-09-26T08:23:42.185Z